Cardiovascular risk assessment in HIV-infected male patients: A comparison of Framingham, SCORE, PROCAM and DAD risk equations

Acta Dermatovenerologica Alpina, Pannonica et Adriatica

Volumn 23, Issue 3, 2014, Pages 43-47

  Pirs, Mateja ^a   Jug, Borut ^b   Eržen, Barbara ^b   Šabović, Mišo ^b   Karner, Primož ^b   Poljak, Mario ^a   Tomažič, Janez ^b  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

5 year DAD risk equation; Framingham Risk Score; HIV infection; PROCAM; SCORE

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; ALGORITHM; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL EVALUATION; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; DAD RISK SCORE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; DYSLIPIDEMIA; FAMILY HISTORY; FRAMINGHAM RISK SCORE; GENDER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PROCAM SCORE; PROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM; SLOVENIA; SMOKING; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; WAIST HIP RATIO; CARDIOVASCULAR DISEASES; COMORBIDITY; COMPARATIVE STUDY; HIV INFECTIONS; MIDDLE AGED;

ADULT; ALGORITHMS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CAROTID INTIMA-MEDIA THICKNESS; COMORBIDITY; CROSS-SECTIONAL STUDIES; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK ASSESSMENT; SLOVENIA;

EID: 84907280015     PISSN: 13184458     EISSN: None     Source Type: Journal    
DOI: 10.15570/actaapa.2014.11     Document Type: Article

References (31)

1. CASCADE Collaboration. Survival after introduction of HAART in people with known duration of HIV-1 infection. The CASCADE Collaboration. Concerted Action on SeroConversion to AIDS and Death in Europe. Lancet. 2000;355:1158-9.
2. Grunfeld C, Kotler DP, Arnett DK, Falutz JM, Haffner SM, Hruz P, et al. Contribution of metabolic and anthropometric abnormalities to cardiovascular disease risk factors. Circulation. 2008;118:e20-8.
3. Delaney JAC, Scherzer R, Biggs ML, Shliplak MG, Polak JF, Currier JS, et al. Associations of antiretroviral drug use and HIV-specific risk factors with carotid intima-media thickness. AIDS. 2010;24:2201-9.
4. Friis-Møller N, Weber R, Reiss P, Thiébaut R, Kirk O, d'Arminio Monforte A, et al. Cardiovascular disease risk factors in HIV patients - association with antiretroviral therapy. Results from the DAD study. AIDS. 2003;17:1179-93.
5. Friis-Møller N, Sabin CA, Weber R, d'Arminio Monforte A, El-Sadr WM, Reiss P, et al. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med. 2003;349:1993-2003.
6. Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab. 2007;92:2506-12.
7. Piconi S, Parisotto S, Rizzardini G, Passerini S, Meraviglia P, Schiavini M, et al. Atherosclerosis is associated with multiple pathogenic mechanisms in HIV-infected antiretroviral-naive or treated individuals. AIDS. 2013;27:381-9.
8. D'Agostino RB. Cardiovascular Risk Estimation in 2012: Lessons learned and applicability to the HIV population. J Infect Dis. 2012;205:362-7.
9. Friis-Møller N, Worm SW. Can the risk of cardiovascular disease in HIV-infected patients be estimated from conventional risk prediction tools? Clin Infect Dis. 2007;45:1082-4.
10. Moreira Guimarães MM, Bartolomeu Greco D, Ingles Garces ÁH, de Oliviera AR Jr, Bastos Foscolo R, de Campos Machado LJ. Coronary heart disease risk assessment in HIV-infected patients: a comparison of Framingham, PROCAM and SCORE risk assessment functions. Int J Clin Pract. 2010;64:739-45.
11. Knobel H, Jericó C, Montero M, Sorli ML, Velat M, Guelar A, et al. Global cardiovascular risk in patients with HIV infection: concordance and differences in estimates according to three risk equations (Framingham, SCORE, and PROCAM). AIDS Patient Care ST. 2007;21:452-7.
12. Edwards-Jackson N, Kerr SJ, Tieu HV, Ananworanich J, Hammer S, Ruxrungtham K, et al. Cardiovascular risk assessment in persons with HIV infection in the developing world: comparing three risk equations in a cohort of HIV-infected Thais. HIV Med. 2011;12:510-5.
13. Kaplan RC, Kingsley LA, Sharrett AR, Li X, Lazar J, Tien PC, et al. Ten-year predicted coronary heart disease risk in HIV-infected men and women. Clin Infect Dis. 2007;45:1074-81.
14. Barros ZM, de Alencar Ximenes RA, Miranda-Filho DB, de Albuquerque Mde F, Melo HR, Carvalho EH, et al. Comparison between the Framingham and prospective cardiovascular of Münster scores for risk assessment of coronary heart disease in human immunodeficiency virus-positive patients in Pernambuco, Brazil. Metab Syndr Relat D. 2010;8:489-97.
15. Friis-Møller N, Thiébaut R, Reiss P, Weber R, Monforte AD, De Wit S, et al. Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study. Eur J Cardiov Prev R. 2010;17:491-501.
16. Nery MW, Martelli CMT, Aparecida Silveira E, Alencar de Sousa C, de Oliviera Falco M, de Cassia Olivieira de Castro A, et al. Cardiovascular risk assessment: a comparison of the Framingham, PROCAM, and DAD equations in HIV-infected persons. Scientific World Journal. 2013;2013:969281.
17. Klavs I, Bergant N, Kustec T, Kastelic Z. Okužba s HIV v Sloveniji - letno poročilo 2006. [HIV Infection in Slovenia - Annual report 2006]. [Internet]. National Institute of Public Health. [cited 2014 May 10]. Available from: http://ivz.si/Mp.aspx?ni=107&pi=5&-5-id=294&-5-PageIndex=0&-5-groupId=221&-5-newsCategory=&-5-action=ShowNewsFull&pl=107-5.0.Slovene.
18. Klavs I, Kustec T, Kastelic Z. Okužba s HIV v sloveniji - Podatki o prijavljenih primerih do vključno 22. novembra 2013. [HIV Infection in Slovenia - Data on reported cases up to 22 November 2013]. [Internet]. National Institute of Public Health [cited 2014 July 10]. Available from: http://www.ivz.si/hiv-spo?pi=5&-5-Filename=attName.png&-5-MediaId=7323&-5-AutoResize=false&pl=107-5.3.Slovene.
19. Pirš M, Eržen B, Šabović M, Karner P, Vidmar L, Poljak M, et al. Early atherosclerosis in HIV-infected patients below the age of 55 - Slovenian national study. Wiener klinische Wochenschrift. 2014;126:263-9.
20. Dubé MP, Stein JH, Aberg JA, Fichtenbaum CJ, Gerber JG, Tashima KT, et al. Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group. Clin Infect Dis. 2003;37:613-27.
21. Assmann G. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation. 2002;105:310-5.
22. Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2012;33:1635-701.
23. Mulligan K, Grunfeld C, Tai VW, Algren H, Pang M, Chernoff DN, et al. Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection. J Acquir Immune Defic Syndr. 2000;23:35-43.
24. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation. 1986;74:1399-406.
25. Hsue PY, Giri K, Erickson S, MacGregor JS, Younes N, Shergill A, et al. Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infection. Circulation. 2004;109:316-9.
26. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med. 1999;340:14-22.
27. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, et al. Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis. 2007;23:75-80.
28. Hadigan C, Meigs JB, Wilson PWF, D'Agostino RB, Davis B, Basgoz N, et al. Prediction of coronary heart disease risk in HIV-infected patients with fat redistribution. Clin Infect Dis. 2003;36:909-16.
29. Maggi P, Quirino T, Ricci E, De Socio GV, Gadaleta A, Ingrassia F, et al. Cardiovascular risk assessment in antiretroviral-naïve HIV patients. AIDS Patient Care ST. 2009;23:809-13.
30. De Socio GVL, Martinelli C, Ricci E, Orofino G, Valsecchi L, Vitiello P, et al. Relations between cardiovascular risk estimates and subclinical atherosclerosis in naive HIV patients: results from the HERMES study. Int J STD AIDS. 2010;21:267-72.
31. Parra S, Coll B, Aragonés G, Marsillach J, Beltran R, Rull A, et al. Nonconcordance between subclinical atherosclerosis and the calculated Framingham risk score in HIV-infected patients: relationships with serum markers of oxidation and inflammation. HIV Med. 2010;11:225-31.